
The Turkish Gynecological Oncology Association (TGOD) has long been a key contributor to advancing research in the field of gynecological oncology. Founded in 1993, TGOD aims to foster high-quality research that improves the understanding, diagnosis, and treatment of gynecological cancers, including ovarian, cervical, endometrial, vaginal, and vulvar cancers. The association actively collaborates with national and international partners to promote clinical trials, translational research, and the development of innovative therapies. Visit trsgokolposkopi2023.org.
TGOD’s focus on research is driven by the need to address the unique challenges posed by gynecological cancers, which remain a leading cause of cancer-related mortality among women in Turkey and worldwide. This article explores TGOD’s key research initiatives, including its role in clinical trials, contributions to personalized medicine, and collaborations with global research institutions.
Promoting Clinical Research and Trials
A central component of TGOD’s work is its commitment to clinical research. Clinical trials provide the scientific …